ANDHealth+ Program
The ANDHealth+ Program provides mid-stage digital health companies with support from proven experts to undertake a significant piece of work focused on securing the clinical and/or commercial evidence to support the raising of growth capital and progress market entry strategy. No transfer of equity or intellectual property rights is required to be a participant in the ANDHealth+ program.

Applications to ANDHealth+ 2018 are Closed. We will announce the ANDHealth+2018 cohort in early July!

Applications are to ANDHealth+ 2018 are closed.

Benefits:

  • Each project selected is supported by:
  • Up to $60,000 to access specialist third party services and activities, as agreed in the project plan.
  • Access to Hands on Support & Advice from ANDHealth’s commercial members with a proven track record in digital health product development and commercialisation.
  • Facilitated introductions to national and international networks of investors, global healthcare and technology companies and specialised service providers.
  • No Equity or Intellectual Property transfer required- no downside!

Application considerations:

  • Tell us about your company and outline a key project which would significantly improve the project’s market entry.
  • Eligible projects will be focus on developing key areas of the technology and/ or business model and can include clinical evidence as well as projects which support the business case.
  • Technologies should have achieved proof of concept/ proof of principle and must be evidence based with a clear focus on changing outcomes for patients.